Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop

Molecular Immunology

Volumn 43, Issue 13, 2006, Pages 2051-2060

  Brouwer, Nannette ^a,b   Dolman, Koert M ^a,b   van Zwieten, Rob ^a,b   Nieuwenhuys, Ed ^a,b   Hart, Margreet ^a,b   Aarden, Lucien A ^a,b   Roos, Dirk ^a,b   Kuijpers, Taco W ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Complement; Factor D; Mannan binding lectin (MBL); Phagocytosis; Properdin; Zymosan

Indexed keywords

COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN F(AB')2 FRAGMENT; MANNAN BINDING LECTIN; OLIGOMER; PROPERDIN; ZYMOSAN;

ARTICLE; BLOOD BANK; CALCULATION; CAUCASIAN; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; MANNAN BINDING LECTIN DEFICIENCY; NEUTROPHIL; OPSONIZATION; PHAGOCYTOSIS; PLASMA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECEIVER OPERATING CHARACTERISTIC; WESTERN BLOTTING; YEAST;

COHORT STUDIES; COMPLEMENT C1Q; COMPLEMENT FACTOR D; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MANNOSE-BINDING LECTIN; NEUTROPHILS; PHAGOCYTOSIS; ZYMOSAN;

EID: 33645850696     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.01.003     Document Type: Article

References (39)

1. Biesma D.H., Hannema A.J., Velzen-Blad H., Mulder L., van Zwieten R., Kluijt I., and Roos D. A family with complement factor D deficiency. J. Clin. Invest. 108 (2001) 233-240
2. Biezeveld M.H., Kuipers I.M., Geissler J., Lam J., Ottenkamp J.J., Hack C.E., and Kuijpers T.W. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet 361 (2003) 1268-1270
3. Brooks A.S., Hammermueller J., DeLay J.P., and Hayes M.A. Expression and secretion of ficolin beta by porcine neutrophils. Biochim. Biophys. Acta 1624 (2003) 36-45
4. Dahl M., Tybjaerg-Hansen A., Schnohr P., and Nordestgaard B.G. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J. Exp. Med. 199 (2004) 1391-1399
5. Dahl M.R., Thiel S., Matsushita M., Fujita T., Willis A.C., Christensen T., Vorup-Jensen T., and Jensenius J.C. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 15 (2001) 127-135
6. Dodds A.W., and Sim R.B. Complement-A Practical Approach (1997), Oxford University Press pp. 1-18
7. Epstein J., Eichbaum Q., Sheriff S., and Ezekowitz R.A. The collectins in innate immunity. Curr. Opin. Immunol. 8 (1996) 29-35
8. Fijen C.A., Kuijper E.J., Hannema A.J., Sjoholm A.G., and van Putten J.P. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 2 (1989) 585-588
9. Gadjeva M., Thiel S., and Jensenius J.C. The mannan-binding-lectin pathway of the innate immune response. Curr. Opin. Immunol. 13 (2001) 74-78
10. Garred P., Larsen F., Madsen H.O., and Koch C. Mannose-binding lectin deficiency-revisited. Mol. Immunol. 40 (2003) 73-84
11. Hayashi F., Means T.K., and Luster A.D. Toll-like receptors stimulate human neutrophil function. Blood 102 (2003) 2660-2669
12. Kase T., Suzuki Y., Kawai T., Sakamoto T., Ohtani K., Eda S., Maeda A., Okuno Y., Kurimura T., and Wakamiya N. Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97 (1999) 385-392
13. Kilpatrick D.C. Isolation of human mannan binding lectin, serum amyloid P component and related factors from Cohn fraction III. Transfus. Med. 7 (1997) 289-294
14. Kilpatrick D.C., Fujita T., and Matsushita M. P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients. Immunol. Lett. 67 (1999) 109-112
15. Kurt-Jones E.A., Mandell L., Whitney C., Padgett A., Gosselin K., Newburger P.E., and Finberg R.W. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100 (2002) 1860-1868
16. Liu Y., Endo Y., Iwaki D., Nakata M., Matsushita M., Wada I., Inoue K., Munakata M., and Fujita T. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J. Immunol. 175 (2005) 3150-3156
17. Madsen H.O., Garred P., Thiel S., Kurtzhals J.A., Lamm L.U., Ryder L.P., and Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. 155 (1995) 3013-3020
18. Madsen H.O., Satz M.L., Hogh B., Svejgaard A., and Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J. Immunol. 161 (1998) 3169-3175
19. Matsushita M., and Fujita T. The role of ficolins in innate immunity. Immunobiology 205 (2002) 490-497
20. Minchinton R.M., Dean M.M., Clark T.R., Heatley S., and Mullighan C.G. Analysis of the relationship between mannose-binding lectin (MBL) genotype. MBL levels and function in an Australian blood donor population. Scand. J. Immunol. 56 (2002) 630-641
21. Neth O., Hann I., Turner M.W., and Klein N.J. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 358 (2001) 614-618
22. Neth O., Jack D.L., Dodds A.W., Holzel H., Klein N.J., and Turner M.W. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68 (2000) 688-693
23. Roos A., Bouwman L.H., Munoz J., Zuiverloon T., Faber-Krol M.C., Fallaux-van den Houten F.C., Klar-Mohamad N., Hack C.E., Tilanus M.G., and Daha M.R. Functional characterization of the lectin pathway of complement in human serum. Mol. Immunol. 39 (2003) 655-668
24. Roos A., Garred P., Wildenberg M.E., Lynch N.J., Munoz J.R., Zuiverloon T.C., Bouwman L.H., Schlagwein N., Fallaux van den Houten F.C., Faber-Krol M.C., Madsen H.O., Schwaeble W.J., Matsushita M., Fujita T., and Daha M.R. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur. J. Immunol. 34 (2004) 2589-2598
25. Roos D., and de Boer M. Purification and cryopreservation of phagocytes from human blood. Methods Enzymol. 132 (1986) 225-243
26. Saifuddin M., Hart M.L., Gewurz H., Zhang Y., and Spear G.T. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J. Gen. Virol. 81 (2000) 949-955
27. Sastry K., Herman G.A., Day L., Deignan E., Bruns G., Morton C.C., and Ezekowitz R.A. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J. Exp. Med. 170 (1989) 1175-1189
28. Seelen M.A., Roos A., Wieslander J., Mollnes T.E., Sjoholm A.G., Wurzner R., Loos M., Tedesco F., Sim R.B., Garred P., Alexopoulos E., Turner M.W., and Daha M.R. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods 296 (2005) 187-198
29. Sim R.B., and Tsiftsoglou S.A. Proteases of the complement system. Biochem. Soc. Trans. 32 (2004) 21-27
30. Skalnikova H., Freiberger T., Chumchalova J., Grombirikova H., and Sediva A. Cost-effective genotyping of human MBL2 gene mutations using multiplex PCR. J. Immunol. Methods 295 (2004) 139-147
31. Steffensen R., Thiel S., Varming K., Jersild C., and Jensenius J.C. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J. Immunol. Methods 241 (2000) 33-42
32. Suankratay C., Zhang X.H., Zhang Y., Lint T.F., and Gewurz H. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. J. Immunol. 160 (1998) 3006-3013
33. Thiel S., Frederiksen P.D., and Jensenius J.C. Clinical manifestations of mannan-binding lectin deficiency. Mol. Immunol. 43 (2006) 86-96
34. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 17 (1996) 532-540
35. Turner M.W. Mannose-binding lectin (MBL) in health and disease. Immunobiology 199 (1998) 327-339
36. Turner M.W. The role of mannose-binding lectin in health and disease. Mol. Immunol. 40 (2003) 423-429
37. Valdimarsson H., Stefansson M., Vikingsdottir T., Arason G.J., Koch C., Thiel S., and Jensenius J.C. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand. J. Immunol. 48 (1998) 116-123
38. Vorup-Jensen T., Petersen S.V., Hansen A.G., Poulsen K., Schwaeble W., Sim R.B., Reid K.B., Davis S.J., Thiel S., and Jensenius J.C. Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J. Immunol. 165 (2000) 2093-2100
39. Worthley D.L., Bardy P.G., and Mullighan C.G. Mannose-binding lectin: biology and clinical implications. Intern. Med. J. 35 (2005) 548-555